12-02 :: February/March 2012
agForce AG (Frankfurt, XETRA: MF6) has completed a share placement with institutio-
nal investors. All of the 825,408 newly issued shares were placed, with profit participation rights dating from January 1, 2011, at a price of EUR5.50 per share. The gross proceeds from the capital increase, in the amount of EUR 4,539,744.00 will be used for further commercialization activities and the clinical development of the NanoTherm®
with the expansion of commercial and strategic part- nerships.
This transaction increases the nominal share capital of the company, from EUR4.127.041, divided into 4,127,041 shares with an imputed nominal value of EUR1.00, to EUR 4,952,495.00.
The very successful capital increase and the meetings with the strategic investors were managed by Silvia Quandt & Cie. AG.
lithium-ion batteries. The transaction additionally co- vers Merck’s respective research portfolio regarding novel electrolytes and additives.
etabolix, Inc. (NASDAQ: MBLX) reported financial results for the three months and full
year ended December 31, 2011. Total revenue in the fourth quarter of 2011 was $0.4 million, com- pared to $0.1 million for the comparable quarter in 2010. Total revenue for the full year 2011 was $1.4 million, compared to $0.4 million, for the compara- ble quarter in 2010.
For the full year, the Company reported a net loss of $38.8 million or $1.24 per share as compared to a net loss of $38.8 million or $1.45 per share for 2010.
erck sells its electrolytes business for high- performance batteries to BASF. The compa-
nies have agreed not to disclose the financial details of the transaction.
The divestment encompasses the tec hnologies and products for enhancing battery performance that Merck has developed, patented and in some cases brought to market. These include the complete line of finished electrolyte formulations that are marke- ted under the SelectiLyte®
variety of additives for electrolytes used to produce
Net cash used in operating activities for the full year was $31.7 million compared to $32.0 million used in 2010. Unrestricted cash and investments at De- cember 31, 2011 totaled $78.4 million. In 2011, the Company raised $49.3 million net proceeds in an offering of common stock and continues to have no debt.
http://www.metabolix.com M brand. Also included is a
ETACLAY, a business based in Karachev, Bry- ansk Oblast, has launched the first production
in Russia of nanosilicates and polymer nanocom- posites incorporating those nanosilicates. The pro- ducts are used as additives and fillers in the oil-and- gas, cable, packaging, and automobile industries.